Cat.#: ASSD-131
| Description | Fluorescent metal ion indicator. Exhibits resistance to alkaline hydrolysis and displays similar calcium-binding properties to calcein. It fluoresces in both acidic and basic solutions when excited by the correct wavelength. Enhanced fluorescence is shown when bound to Ca (II), La (II) and Zn (II). Reduced fluorescence is shown when bound to Fe (II), Cu (II), Ni (II), Mn (II) and Co (II). |
| Size | 1 mg |
| Molecule Weight | 321.28 |
| Molecular formula | C15H15NO7 |
| CAS Number | 54375-47-2 |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-129 | Fluorescent 5-HT1A antagonist [NAN-190] (AC129) | 50 μg | inquiry |
| ASSD-163 | Ponceau S sodium salt (AC163) | 25 g | inquiry |
| ASSD-137 | CCR2 covalent NAM (AC137) | 50 μg | inquiry |
| ASSD-175 | 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) | 25 mg | inquiry |
| ASSD-145 | Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) | 1 mL | inquiry |
| ASSD-146 | Pyronin Y (AC146) | 1 g, 5g | inquiry |
| ASSD-141 | MTT (AC141) | 500 mg, 1 g | inquiry |
| ASSD-149 | D-Luciferin sodium salt (AC149) | 10 mg, 50 mg, 100 mg | inquiry |
| ASSD-217 | t-Boc-MTSEA-Fluorescein (AC217) | 10 mg | inquiry |
| ASSD-210 | 7-Amino-4-methyl-3-coumarinacetic acid N-succinimidyl ester (AC210) | 5 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.